(Q84357726)
Statements
The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy (English)
Elliott D Crouser
Gerard Lozanski
Charity C Fox
David W Hauswirth
Rekha Raveendran
scientific article published on 01 June 2010